Childhood Cancer STAR Reauthorization Act of 2022
Summary
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2022
Committee Review
Floor Vote
President
Introduced Apr 28, 2022
Last action Apr 29, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Apr 29, 2022
Committee
Referred to the Subcommittee on Health.
lower
Apr 28, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Apr 28, 2022
Introduced
Introduced in House
lower
1 primary · 109 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Michael T. McCaul
RRepublican
Co
A. Donald McEachin
DDemocratic
Co
Ami Bera
DDemocratic
Co
Andrew R. Garbarino
RRepublican
Co
André Carson
DDemocratic
Co
Ann M. Kuster
DDemocratic
Co
Barbara Lee
DDemocratic
Co
Betty McCollum
DDemocratic
Co
Bill Posey
RRepublican
Co
Bob Gibbs
RRepublican
Co
Bobby L. Rush
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 7630
Scope: US
Hi! I can help you understand HR 7630. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline